Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1
-
Catalog number7-04521
-
PricePlease ask
-
Size1mg
-
-
Shelf lifeThe shelf life of this product is 12 mois
-
StorageThe storage of this product is at: -20℃
-
ShippingThe shipping of this product is in: RT
-
DescriptionFor cells, cell lines and tissues in culture till half confluency.
-
PropertiesHuman proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
-
SourceRecombinants or rec. proteins
-
Grouprecombinants
-
Gene target
-
Short nameRecombinant B- Leukemia/Lymphoma 2 -BH1
-
TechniqueRecombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. CHI Scientific advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
-
SpeciesHuman, Humans
-
Alternative nameRec. H. sapiens B-cellular Leukemia/Lymphoma 2 -BH1
-
Alternative techniquerec
-
Tissuecell
-
Virusleukemia
-
MeSH Data
-
Name
-
ConceptScope note: Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
-
Tree numbers
- C04.557.337.372
- C04.619.531
- E05.598.500.496.500
-
Qualifiersdiagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, rehabilitation, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, psychology, urine, virology, history, classification, economics, embryology, genetics, nursing, radiotherapy, ethnology, prevention & control, pathology, metabolism, complications, surgery